Cell shape-dependent pathway of plasminogen activator inhibitor type-1 gene expression requires cytoskeletal reorganization

J Cell Physiol. 1998 Aug;176(2):293-302. doi: 10.1002/(SICI)1097-4652(199808)176:2<293::AID-JCP7>3.0.CO;2-J.

Abstract

Synthesis of plasminogen activator inhibitor type-1 (PAI-1), a major physiological modulator of plasmin generation, is regulated by growth factors and changes in cell shape. To evaluate the specific relationship between PAI-1 gene expression and cytoarchitecture, serum-free cultures of quiescent rat kidney (NRK) cells were exposed to cytochalasin D (CD) at concentrations that disrupt microfilament structure. Treatment with 1-10 microM CD resulted in an increased 1) incidence of rounded cells, 2) relative PAI-1 mRNA content, and 3) fraction of PAI-1 protein-expressing cells. Abrupt increases in each response were evident at a final concentration of 5 microM CD. Maximal levels of induced PAI-1 transcripts (18-fold that of control) occurred 4 hours post-CD addition and declined thereafter but remained elevated (by at least tenfold) for 24 hours. Assessment of the metabolic requirements for CD-induced PAI-1 expression by using the protein synthesis inhibitors puromycin and cycloheximide indicated that PAI-1 transcripts were regulated in a complex manner in response to CD. The predominant mode of induction reflected secondary (protein synthesis-dependent) metabolic processes, although a minor, albeit significant, primary (protein synthesis-independent) pathway was also evident. PAI-1 mRNA levels in NRK cells maintained in serum- and CD-free agarose suspension culture were low or undetectable. Relative abundance of PAI-1 transcripts in suspended cells cultured in the presence of CD, however, closely approximated that of plastic-adherent, CD-treated cells (13-fold over control). NRK cells in suspension culture with or without CD were morphologically identical, remaining spherical and unattached. It appears, therefore, that cell rounding alone is not a sufficient stimulus to induce PAI-1 expression in quiescent NRK cells and that perturbation of the actin skeleton as a consequence of CD treatment is a critical event in the inductive response. A protein tyrosine kinase is likely involved in the CD-mediated signal-transduction cascade, since induced PAI-1 expression can be down-regulated by genistein and herbimycin A but not by calphostin C or tyrphostin B46.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benzoquinones
  • Cell Line
  • Cell Size / genetics
  • Cycloheximide / pharmacology
  • Cytochalasin D / pharmacology
  • Cytoskeleton / physiology*
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Genistein / pharmacology
  • Kidney / cytology*
  • Kidney / enzymology
  • Kinetics
  • Lactams, Macrocyclic
  • Naphthalenes / pharmacology
  • Nitriles / pharmacology
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Protein Synthesis Inhibitors / pharmacology
  • Protein-Tyrosine Kinases / metabolism
  • Puromycin / pharmacology
  • Quinones / pharmacology
  • RNA, Messenger / metabolism
  • Rats
  • Rifabutin / analogs & derivatives
  • Tyrphostins*

Substances

  • Benzoquinones
  • Enzyme Inhibitors
  • Lactams, Macrocyclic
  • Naphthalenes
  • Nitriles
  • Nucleic Acid Synthesis Inhibitors
  • Plasminogen Activator Inhibitor 1
  • Protein Synthesis Inhibitors
  • Quinones
  • RNA, Messenger
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-(3-phenylpropyl)cinnamide
  • Rifabutin
  • Cytochalasin D
  • Puromycin
  • herbimycin
  • Cycloheximide
  • Genistein
  • Protein-Tyrosine Kinases
  • calphostin C